Consort Medical PLC | Balance Sheet

Fiscal year is May-April. All values GBP Thousands.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
25,850.00
45,201.00
16,258.00
22,200.00
21,400.00
13,500
Total Accounts Receivable
27,975.00
62,530.00
60,055.00
65,600.00
75,400.00
69,800
Inventories
10,203.00
31,344.00
30,725.00
34,400.00
35,200.00
47,100
Other Current Assets
-
-
3,861.00
-
-
-
Total Current Assets
64,028.00
139,075.00
110,899.00
122,200.00
132,000.00
130,400
Net Property, Plant & Equipment
49,955.00
128,012.00
136,673.00
143,600.00
147,700.00
152,500
Total Investments and Advances
4,068.00
6,266.00
8,250.00
11,400.00
11,400.00
11,600
Long-Term Note Receivable
4,841.00
1,059.00
-
-
3,800.00
5,400
Intangible Assets
20,835.00
194,350.00
189,938.00
183,900.00
177,200.00
165,700
Total Assets
145,581.00
476,850.00
454,625.00
472,200.00
472,100.00
465,600
ST Debt & Current Portion LT Debt
-
144,414.00
113,209.00
112,000.00
116,900.00
Accounts Payable
6,133.00
24,120.00
61,705.00
67,100.00
71,400.00
Income Tax Payable
1,842.00
-
-
-
-
Other Current Liabilities
9,893.00
54,419.00
3,866.00
2,700.00
3,600.00
Total Current Liabilities
17,868.00
222,953.00
178,780.00
181,800.00
191,900.00
Provision for Risks & Charges
3,906.00
22,915.00
29,783.00
44,900.00
16,000.00
Deferred Taxes
3,429.00
22,401.00
18,571.00
13,800.00
16,200.00
Other Liabilities
-
-
9,475.00
8,500.00
1,700.00
Total Liabilities
27,057.00
276,357.00
245,474.00
260,100.00
225,800.00
Common Equity (Total)
118,524.00
200,493.00
209,151.00
212,100.00
246,300.00
Total Shareholders' Equity
118,524.00
200,493.00
209,151.00
212,100.00
246,300.00
Total Equity
118,524.00
200,493.00
209,151.00
212,100.00
246,300.00
Liabilities & Shareholders' Equity
145,581.00
476,850.00
454,625.00
472,200.00
472,100.00

About Consort Medical

View Profile
Address
Breakspear Park
Hemel Hempstead Hertfordshire HP2 4TZ
United Kingdom
Employees -
Website http://consortmedical.com
Updated 07/08/2019
Consort Medical Plc engages in the design, development, manufacture, and sale of medical drug delivery devices. It operates through two segments: Bespak and Aesica. The Bespak segment develops and produces drug delivery devices, which serves pharmaceutical companies with inhaler and auto-injector technologies.